Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, Gianenrico Senna, Giovanni Passalacqua, Antonio Spanevello, Stefano Aliberti, Diego Bagnasco, Marco Bonavia, Matteo Bonini, Luisa Brussino, Caterina Bucca, Maria F. Caiaffa, Cecilia Calabrese, Gianna Camiciottoli, Marco Caminati, Giovanna E. Carpagnano, Cristiano Caruso, Stefano Centanni, Maria E. Conte, Angelo G. Corsico, Lorenzo Cosmi, Maria T. Costantino, Nunzio Crimi, Simona D’Alò, Maria D'Amato, Stefano Del Giacco, Alessandro Farsi, Elisabetta Favero, Maria P. Foschino Barbaro, Gabriella Guarnieri, Giuseppe Guida, Manuela Latorre, Salvatore Lo Cicero, Carlo Lombardi, Luigi Macchia, Francesco Mazza, Francesco Menzella, Manlio Milanese, Marcello Montagni, Paolo Montuschi, Eleonora Nucera, Roberta Parente, Vincenzo Patella, Girolamo Pelaia, Laura Pini, Francesca Puggioni, Luisa Ricciardi, Fabio L.M. Ricciardolo, Luca Richeldi, Erminia Ridolo, Giovanni Rolla, Pierachille Santus, Nicola Scichilone, Giuseppe Spadaro, Andrea Vianello, Vittorio Viviano, Mona R. Yacoub, Maria C. Zappa, Enrico Heffler
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Elsevier 2020-10-01
Loạt:	World Allergy Organization Journal
Những chủ đề:	Severe asthma Biologics Oral corticosteroids Real-life Registr
Truy cập trực tuyến:	http://www.sciencedirect.com/science/article/pii/S1939455120303677

Những quyển sách tương tự

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
Bằng: Claudia Crimi, et al.
Được phát hành: (2023-11-01)

Nasal polyps impact in severe asthma patients: evidences from the SANI
Bằng: Giorgio Walter Canonica, et al.
Được phát hành: (2020-08-01)

Economic impact of a more extensive use of FENO testing on the Italian population with asthma
Bằng: Carla Rognoni, et al.
Được phát hành: (2023-06-01)

Asthma severity: the patient’s point of view
Bằng: Gabriella Guarnieri, et al.
Được phát hành: (2024-12-01)

Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
Bằng: Giovanna Elisiana Carpagnano, et al.
Được phát hành: (2023-10-01)

Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma
Bằng: Diego Bagnasco, et al.
Được phát hành: (2020-08-01)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
Bằng: Diego Bagnasco, et al.
Được phát hành: (2021-02-01)

Severe asthma: One disease and multiple definitions
Bằng: Diego Bagnasco, MD, PhD, et al.
Được phát hành: (2021-11-01)

Critical evaluation of asthma biomarkers in clinical practice
Bằng: Giuseppe Guida, et al.
Được phát hành: (2022-10-01)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
Bằng: Paolo Solidoro, et al.
Được phát hành: (2022-01-01)

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
Bằng: Marco Caminati, MD, et al.
Được phát hành: (2024-08-01)

Phenotype overlap in the natural history of asthma
Bằng: Fabio L.M. Ricciardolo, et al.
Được phát hành: (2023-05-01)

Minimal clinically important difference for asthma endpoints: an expert consensus report
Bằng: Matteo Bonini, et al.
Được phát hành: (2020-06-01)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Bằng: Diego Bagnasco, et al.
Được phát hành: (2023-08-01)

Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies
Bằng: Giorgio Walter Canonica, et al.
Được phát hành: (2021-09-01)

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
Bằng: Giorgio Walter Canonica, MD, et al.
Được phát hành: (2025-01-01)

Tezepelumab: patient selection and place in therapy in severe asthma
Bằng: Francesco Menzella, et al.
Được phát hành: (2024-04-01)

Treatment strategies for asthma: reshaping the concept of asthma management
Bằng: Alberto Papi, et al.
Được phát hành: (2020-08-01)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
Bằng: Giulia Scioscia, et al.
Được phát hành: (2020-03-01)

Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
Bằng: Diego Bagnasco, et al.
Được phát hành: (2020-08-01)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
Bằng: Dejan Radovanovic, et al.
Được phát hành: (2017-05-01)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
Bằng: Corrado Pelaia, et al.
Được phát hành: (2023-03-01)

Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma
Bằng: Francesca Bertolini, et al.
Được phát hành: (2025-02-01)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
Bằng: Dejan Radovanovic, et al.
Được phát hành: (2017-06-01)

Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
Bằng: Erminia Ridolo, et al.
Được phát hành: (2020-10-01)

Brittle asthma
Bằng: O. Toungoussova, et al.
Được phát hành: (2016-02-01)

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Bằng: Alessandra Vultaggio, et al.
Được phát hành: (2023-05-01)

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
Bằng: Lacedonia D, et al.
Được phát hành: (2017-06-01)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
Bằng: Giovanna Elisiana Carpagnano, et al.
Được phát hành: (2021-03-01)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
Bằng: G. Senna, et al.
Được phát hành: (2017-04-01)

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
Bằng: Maria D'Amato, et al.
Được phát hành: (2022-05-01)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
Bằng: Paolo Solidoro, et al.
Được phát hành: (2019-04-01)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
Bằng: Francesco Menzella, et al.
Được phát hành: (2016-12-01)

Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
Bằng: Carlo Lombardi, et al.
Được phát hành: (2024-11-01)

The extracellular matrix of the lung and airway responsiveness in asthma
Bằng: F.G. Salerno, et al.
Được phát hành: (2016-01-01)

Alexithymia and asthma: a systematic review
Bằng: Orlando Silvestro, et al.
Được phát hành: (2023-08-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
Bằng: Carlo Lombardi, et al.
Được phát hành: (2024-07-01)

“Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study”
Bằng: Laura Losappio, et al.
Được phát hành: (2019-06-01)

Interleukin-5 in the Pathophysiology of Severe Asthma
Bằng: Corrado Pelaia, et al.
Được phát hành: (2019-12-01)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
Bằng: Paolo Montuschi
Được phát hành: (2010-06-01)